RAPT Therapeutics (RAPT) Current Assets (2020 - 2024)
Historic Current Assets for Therapeutics (RAPT) over the last 5 years, with Q3 2024 value amounting to $102.6 million.
- Therapeutics' Current Assets fell 4517.52% to $102.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $102.6 million, marking a year-over-year decrease of 4517.52%. This contributed to the annual value of $161.8 million for FY2023, which is 3597.71% down from last year.
- As of Q3 2024, Therapeutics' Current Assets stood at $102.6 million, which was down 4517.52% from $120.5 million recorded in Q2 2024.
- Over the past 5 years, Therapeutics' Current Assets peaked at $252.7 million during Q4 2022, and registered a low of $102.6 million during Q3 2024.
- In the last 5 years, Therapeutics' Current Assets had a median value of $175.7 million in 2022 and averaged $171.6 million.
- Its Current Assets has fluctuated over the past 5 years, first soared by 7120.25% in 2022, then tumbled by 4517.52% in 2024.
- Therapeutics' Current Assets (Quarter) stood at $115.6 million in 2020, then surged by 66.93% to $193.0 million in 2021, then surged by 30.95% to $252.7 million in 2022, then plummeted by 35.98% to $161.8 million in 2023, then plummeted by 36.58% to $102.6 million in 2024.
- Its Current Assets stands at $102.6 million for Q3 2024, versus $120.5 million for Q2 2024 and $148.4 million for Q1 2024.